AbbVie’s ABBV 2024 revenue grew 4.6% on a constant currency basis, with 2025 guidance of 5.7% growth and new 2027 guidance for combined sales of immunology drug Skyrizi and Rinvoq of $31 billion (up ...

With that being said, let’s move to the 10 best stocks for beginners with little money according to hedge funds.

Shares of weight-loss drug developer Metsera jumped nearly 42% in a strong Nasdaq debut on Friday, valuing the ARCH Venture ...

Vertex Pharmaceuticals (VRTX – Research Report) received a Buy rating and a $480.00 price target from Cantor Fitzgerald analyst Olivia Brayer ...

Summers Value Partners, an investment management company, released its fourth quarter 2024 investor letter. A copy of the ...

These healthcare REITs are rated Buy at Jefferies and make sense now for investors seeking dependable passive income and a ...

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Fresenius Medical Care has seen 18.5% growth, with strong prospects. Learn why FMS stock’s fair value of $34/share makes it a ...

The final move, made by Larry Culp, was to break GE into three businesses: GE Verona, GE Healthcare , and GE Aerospace. The ...

European shares were at a record high on Friday, led by technology and healthcare stocks, even as caution prevailed ahead of ...

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.

DeepSeek's AI model causes tech stocks to drop, but healthcare tech ETFs benefit from advancements in AI without vulnerability to market volatility.